Crossref
Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility
Engineered Science · 2026
DOI: 10.30919/es2173 ↗At a glance
Journal article in Engineered Science, 2026. Written by Reem Darwesh, and 3 co-authors. Cited 1 times so far (Crossref).
Abstract (original language)
Intet abstract tilgængeligt.
Cite
APA
Darwesh,, R., Sofi, B. F., Elbialy, N. S., & Alsalah, J. H. (2026). Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. https://doi.org/10.30919/es2173
Vancouver
Darwesh, R, Sofi BF, Elbialy NS, Alsalah JH. Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. 2026. doi:10.30919/es2173
BibTeX
@article{Darwesh2026,
author = {Darwesh,, Reem and Sofi, Balsam Fahad and Elbialy, Nihal S. and Alsalah, Jaber Hussain},
title = {Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility},
journal = {Engineered Science},
year = {2026},
doi = {10.30919/es2173}
}
EUVIMED